We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multi-Bay Modular Real Time PCR Instrument Enables Rapid Onsite Nucleic Acid Testing

By LabMedica International staff writers
Posted on 02 Nov 2023

A new generation of compact and inexpensive molecular testing platforms features a unique ultra-low-light CMOS sensor technology that enables the detection of infectious or oncology markers, as well as pathogens in the food and environment. More...

Anitoa Systems (Sunnyvale, CA, USA) has launched new 96-well multi-bay modular real-time PCR (qPCR) instruments in its Maverick line of qPCR products. Anitoa's Maverick multi-bay modular qPCR instrument MQx96 is the company’s first larger format qPCR instrument that comes with multiple independently operable modules. The MQx96 and MQx48 instruments are available in 96 (6X16) and 48 (3X16) well formats, and feature 6X or 3X 16-well qPCR modules, both of which can be independently controlled using a unified software interface. MQx96 is ideal for laboratories that are required to run small sample batches continuously in a pipelined manner.

Maverick qPCR instruments feature technological innovations, including a unique proprietary low-light complementary metal-oxide-semiconductor (CMOS) 4-channel fluorescence optics system that enables rapid and highly multiplexed DNA detection. Additionally, Maverick qPCR instruments are easy to use and do not need calibration, thanks to their solid-state construction. Apart from their operational flexibility, Anitoa's MQ96 (and MQ48) are modular systems with each reaction chamber independently heated and cooled. This enables the instruments to achieve a 30-40% faster reaction time compared to traditional large-block qPCR systems.

"We are excited to offer laboratories worldwide a modular solution for rapid and pipelined nucleic acid tests to help combat diseases by detecting pathogens in human, as well as our food and environment," said Dr. Zhimin Ding, CEO of Anitoa Systems. "We believe our multi-bay modular qPCR instruments and the integrated software offer features that meet the needs of labs seeking higher throughput testing while being extremely flexible."

Related Links:
Anitoa Systems


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Capillary testing on the Atellica analyzers supports the most common laboratory testing needs (Photo courtesy of Siemens Healthineers)

Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers

Venous blood draws can be challenging in patients with difficult veins, needle phobia, or limited blood volume, and they can slow collection in busy services. Core laboratories also face pressure to expand... Read more

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.